The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
about
Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Neural substrates underlying effort, time, and risk-based decision making in motivated behavior.Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.Anterior cingulate cortex supports effort allocation towards a qualitatively preferred option.Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.
P2860
Q35203638-C27500E7-42CD-4CCB-9145-F688AC873290Q38836831-1AEB3FCD-C18A-4EE9-B1EA-6719DDAE5B93Q38900272-3603E03C-E173-408F-B088-C93FBF80A134Q40093821-5DA72291-EC97-4770-B9D1-57CB1FD260C1Q41249072-89774ECF-A7FE-41CD-9287-FD5F171913C1Q43096386-3BDA4043-DF28-4FE4-986C-7A6731D2E8C1Q46423534-9E402FD3-C841-4D91-AAC2-F7CE7AADB2C0Q47372013-984260AB-1706-4BBB-ADA0-F45B6D35E2B6Q47586487-6F15BA70-1189-4250-AB65-7F83BB142BBAQ47680336-B7A66D0D-633F-45CE-8CF9-BD105AE4E14AQ48190081-69383855-F7B8-49A7-8BAA-F2EB54947639Q52599712-3CADA85F-C6B8-4310-AEB4-03A7A5AA37BE
P2860
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The VMAT-2 inhibitor tetrabena ...... sal with antidepressant drugs.
@ast
The VMAT-2 inhibitor tetrabena ...... sal with antidepressant drugs.
@en
type
label
The VMAT-2 inhibitor tetrabena ...... sal with antidepressant drugs.
@ast
The VMAT-2 inhibitor tetrabena ...... sal with antidepressant drugs.
@en
prefLabel
The VMAT-2 inhibitor tetrabena ...... sal with antidepressant drugs.
@ast
The VMAT-2 inhibitor tetrabena ...... sal with antidepressant drugs.
@en
P2093
P2860
P50
P1433
P1476
The VMAT-2 inhibitor tetrabena ...... rsal with antidepressant drugs
@en
P2093
Alex Makriyannis
Bilal Khan
Christie A Lee
Eric J Nunes
Patrick A Randall
Priya Shah
Saagar Pandit
Samantha E Yohn
V Kiran Vemuri
Victoria Nowak
P2860
P304
P356
10.1371/JOURNAL.PONE.0099320
P407
P577
2014-06-17T00:00:00Z